We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Atomo的血检产品亮相2014 AACC并荣获头奖

By LabMedica International staff writers
Posted on 11 Sep 2014
Print article
澳大利亚墨尔本的Atomo诊断公司继在墨尔本举行的第20届国际艾滋病大会上成功亮相后,又在2014 AACC年会暨临床化验博览会上展出了一款一体化快速验血设备,面向美国市场。AtomoRapid全合一血液检验兼容多种病症的检测试纸,包括乳糜泻、过敏以及疟疾和人类免疫缺陷病毒(HIV)等传染病。

用该设备能在现场或家里进行更简单、更安全和更准确的检验,从而产生更好的临床结果。

在2014艾滋病大会上,Atomo诊断公司参加了世界卫生组织(WHO; Basel, Switzerland)组织的专场会议。专场会议的焦点是自助化验面临的机会和挑战以及讨论现实世界的情况。AtomoRapid全合一血检产品只有半个iPhone那么大,已在南非用于检测HIV和疟疾检验,欧盟正在进行临床实验,亚洲和美国的临床实验正在筹备。

前ResMed首席执行官、Atomo诊断公司创始人暨CEO John Kelly评论说:“我们从HIV和疟疾做起,因为在现场使用其它现有产品假阴性和假阳性有时超过10%,这对个人的影响最严重。”

澳大利亚政府计划放松对家庭HIV检验的限制,AtomoRapid HIV对于支持这一计划可能发挥重要作用。新南威尔士大学科尔比研究所最新的年度HIV监测报告称, 澳大利亚约30%的HIV患者被诊断出来时已过了本应开始治疗以恢复受损免疫系统的最佳时机。

John Kelly补充说:“我们与南非戴斯蒙•图图HIV基金会的合作研究表明,家庭检验如果要被接受,需要有能减少检验差错的一体化的直观解决方案。”Kelly的女儿得了一种儿童病,需要接受常规抽血做诊断检验,Kelly受此启发,发现了一种更好的验血方法。

AtomoRapid简便易用,因而能够实质性提高社区和家庭检验的可接受度和可靠性。该公司目前正计划在澳大利亚、美国和欧洲发布该产品的专业版和家用版。

每年全球售出逾1亿快速HIV检验,Atomo诊断公司正凭借其AtomoRapid创新向更用户友好的全合一解决方案过渡。

AtomoRapid上个月在纽约举行的医学设计优胜奖(MDEA)颁奖大会上荣获头奖,还被授予诸多其它殊荣。

Related Links:
Atomo诊断公司
世界卫生组织
科尔比研究所


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.